New effort can help beat China in biotech race — if RFK Jr. doesn't hold it back

New effort can help beat China in biotech race — if RFK Jr. doesn't hold it back

For years, American policymakers, researchers, and security experts have warned the United States’s narrowing advantage in clinical research could threaten our dominance in medical innovation. Recognizing the need to address the bottlenecks that make initiating a new trial so costly and cumbersome, Health and Human Services Secretary Robert F. Kennedy Jr. recently announced a new effort to accelerate clinical research, dubbed Operation TrialBlaz…